echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > "China's lymphoma patients throughout the management of quality control standards" issued to promote the standardization of lymphoma diagnosis and treatment

    "China's lymphoma patients throughout the management of quality control standards" issued to promote the standardization of lymphoma diagnosis and treatment

    • Last Update: 2021-01-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    In order to implement the State Council's Action Plan for Further Improving Medical Services, promote the landing of the "Healthy China 2030 Plan" and increase the overall cancer survival rate by 15% in 5 years, the "Full Management of Lymphoma Patients in China" was released live on the National Health and Health Commission's People's Health Television Channel, co-sponsored by the Beijing Love Spectrum Cancer Patient Care Foundation, Roche Pharmaceuticals China. Quality control standards, aimed at improving public awareness of lymphoma diseases, promote the standardized diagnosis and treatment of lymphoma in China, to meet the needs of lymphoma patients, the future will also vigorously promote clinical "medical, nursing, patient" integration of the entire management and treatment model, improve the quality of life of lymphoma patients, so that more lymphoma patients to the road to cure.
    Professor Ma Jun network network to participate in the "China lymphoma patients throughout the management of quality control standards" release (left): Professor Zhu Jun, (middle) Professor Shi Amli, (right) Yan Xia chief nurse China's lymphoma status quo misdiagnosis rate high cure rate low lymphoma is a common malignant tumor originating from the lymphatic hematosis system, but also in recent years, one of the higher incidence of tumors.
    2018 global cancer statistics, the number of people with lymphoma in China is about 260,000.
    , there are about 100,000 new lymphoma patients in China every year, and the incidence of the population is younger trend, the prevention and treatment situation is serious.
    2019 China Lymphoma Patient Survival Report White Paper shows that 43% of patients have experienced misdiagnosis, 51% of patients have been diagnosed through multiple hospitals;
    Professor Ma Jun, Director of Harbin Institute of Hematological Oncology, said: "Research shows that only 22.1% of patients with diffuse large B-cell lymphoma are treated with standardized 8 or more courses of treatment, indicating that the current situation of lymphoma patients in China to receive standardized treatment is not ideal, treatment compliance is also relatively poor, seriously affecting the quality of life of patients."
    refore, lymphoma as a synthesis that takes into account the characteristics of chronic disease and tumor, lymphoma patients from the doctor to guide, promote standardized diagnosis and treatment, to the rehabilitation period follow-up of the whole process of management is particularly important.
    "Lymphoma patients do not need to manage the whole process of standardized diagnosis and treatment for China's lymphoma patients face high misdiagnosis rate, treatment and follow-up compliance with poor and other practical problems, need to learn from foreign cancer patients' individual full management model, carry out a comprehensive, large-scale "lymphoma patients full management" work, aimed at promoting the standardized diagnosis and treatment of lymphoma, strengthen the full management of lymphoma patients, improve the quality of life and survival rate of patients.
    The "China Lymphoma Patients Full Management Quality Control Standard" clearly defined the concept of "Lymphoma Patients Full Management", including patient consultation guidance, standardized diagnosis and treatment promotion and rehabilitation follow-up three parts, through multidisciplinary diagnosis and treatment team to guide potential lymphoma patients to carry out relevant examinations to achieve early diagnosis;
    improve the misdiagnosis and psychological burden of patients, improve the overall survival rate of patients.
    , strengthening the standardized diagnosis and treatment of patients with lymphoma and full management is very important to improve the cure rate of lymphoma.
    " lymphoma standardized diagnosis and treatment has always been the concept of clinical unchanged.
    " Professor Zhu Jun, Party Secretary of Peking University Cancer Hospital and Director of the Lymphoma Department, said, "In the 1990s, the original research lytoxides entered the clinic, And China has made remarkable improvements in the treatment of lymphoma, and the cure rate has increased significantly."
    , more and more innovative treatment options have emerged, bringing new options and hope to the treatment of lymphoma patients.
    need more attention to patient pain points, with case-by-case management model, to carry out extensive and comprehensive management of diagnosis and treatment.
    for patients should also carry out the corresponding disease education and follow-up management, to ensure the compliance of patients with regular follow-up visits, to establish a patient-centered, medical, medical, patient consultation and treatment integration of the whole management model.
    " full management multi-party building care patients to win the treatment of lymphoma patients full management care consultant refers to as a "link" closely linked patients and treatment team, the whole process involved in patient treatment and rehabilitation of medical workers.
    as the most contact with lymphoma patients throughout the management care consultant, has played a key role in disease management, can help improve patient treatment compliance and other issues.
    The whole process management care consultant is mainly responsible for patient visit guidance, standardized diagnosis and rehabilitation follow-up, diagnosis and treatment management, and provide information, emotional and psychological support services for patients to provide comprehensive, full, continuous care and care.
    The diagnosis to treatment to follow-up of lymphoma is a very long process, covering the diagnosis, care, psychology and other aspects of patients with lymphoma," said Yan Xia, chief nurse of hematology department at Peking University People's Hospital.
    standardized specialist care is an indispensable part of the whole management of lymphoma, which can bring great benefits to patients.
    The whole management care consultant is the core role in the standardization of nursing, the whole process management service for patients, to provide practical help to patients, and the whole management of lymphoma and the improvement of specialized nursing capacity is complementary, in improving the quality of patient care at the same time, but also make excellent care consultants become nursing experts.
    ", the release of the "China Lymphoma Patients Full Management Quality Control Standard" by the country's 19 deans, professors and a large number of health care workers to participate in the co-construction, as one of the sponsors of the Standard, Beijing Love Spectrum Cancer Patient Care Foundation Management Committee Chairman, China Anti-Cancer Association Rehabilitation Branch Chairman Shi An "This year is the fifth anniversary of the release of the 'Healthy China 2030' policy, and with the gradual progress of the National Health China Initiative 2030, tumors have been treated as chronic diseases throughout the life cycle, and many mid- to late-stage cancer treatments have gradually move closer to chronic disease management," Professor Leigh said.
    with the continuous improvement of the diagnosis and treatment model, the whole management model has become more and more familiar with and accepted by the public and patients.
    believes that more lymphoma patients will benefit from longer-term survival in the future as the model is rolled out in hospitals across the country.
    "attached to the "Chinese lymphoma patients throughout the management of quality control standards" issued by the list of experts Medical Valley Network Source: Medical Valley Network Copyright Notice: All the text, pictures and audio and video materials on this website indicating "Source: Metz Medicine" or "Source: MedSci Original" are owned by Mays Medical, not authorized, any media, website or individual shall be reproduced, authorized to reproduce with the words "Source: Meis Medicine".
    all reprinted articles on this website are for the purpose of transmitting more information and clearly indicate the source and author, and media or individuals who do not wish to be reproduced may contact us and we will delete them immediately.
    at the same time reproduced content does not represent the position of this site.
    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.